Department of Otolaryngology-Head and Neck Surgery, Georgia Health Sciences University, Augusta, Georgia 30912, USA.
Laryngoscope. 2013 Jan;123(1):233-8. doi: 10.1002/lary.23651. Epub 2012 Sep 5.
OBJECTIVES/HYPOTHESIS: In 2006, a tertiary academic medical center's adult and pediatric cochlear implant program was closed due to financial losses. Using business practices known as supply chain and revenue management, the objective was to establish a new cochlear implant program that was financially viable.
Retrospective cohort study using a nonequivalent historical comparison group design.
Using available financial data from the period of 1999 to 2006, cost and revenue figures were estimated, and a business plan developed using supply chain and revenue management principles to re-establish the cochlear implant program in 2007. Actual cost and revenue data from 2007 to 2011, the current program, were assessed for current financial performance and compared to the historical data.
In comparing the period of 1999 to 2006 to the period of 2007 to 2011, the net loss per implanted patient went from $22,365 to $976. Profitable gross and net margins were achieved for all payers except Medicaid, for which the loss per case remained unchanged. This per case loss may change with receipt of pending Medicaid Upper Payment Limit supplemental payments.
Use of supply chain and revenue management principles markedly improved the financial performance of the re-established cochlear implant program. With improved cost and revenue outcomes, the overall negative net margin was reduced. Physicians who learn and use supply chain and revenue management methods can work to ensure that their patients will have continued access to cochlear implant surgery, and are applicable to any clinical services or procedures that must meet the challenge of achieving financial sustainability.
目的/假设:2006 年,由于财务损失,一家三级学术医疗中心的成人和儿科人工耳蜗植入项目关闭。利用供应链和收入管理等商业实践,目标是建立一个新的财务可行的人工耳蜗植入项目。
使用非等效历史对照设计的回顾性队列研究。
利用 1999 年至 2006 年期间的可用财务数据,估算成本和收入数据,并使用供应链和收入管理原则制定业务计划,以在 2007 年重新建立人工耳蜗植入项目。评估 2007 年至 2011 年现行项目的实际成本和收入数据,以评估当前财务业绩,并将其与历史数据进行比较。
将 1999 年至 2006 年期间与 2007 年至 2011 年期间进行比较,每位植入患者的净亏损从 22365 美元降至 976 美元。除医疗补助计划外,所有支付者的毛利润和净利润均实现盈利,而每例病例的亏损保持不变。这种每例病例的损失可能会随着即将收到的医疗补助上限补充付款而改变。
使用供应链和收入管理原则显著改善了重新建立的人工耳蜗植入项目的财务业绩。随着成本和收入结果的改善,整体负净利润率降低。学习和使用供应链和收入管理方法的医生可以努力确保他们的患者将继续获得人工耳蜗植入手术的机会,并且适用于任何必须应对实现财务可持续性挑战的临床服务或程序。